Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Euro Falls Ahead Of ECB Policy Meeting

Published 12/09/2021, 12:10 PM
Updated 09/29/2021, 03:25 AM

The euro has reversed directions on Thursday and has posted losses. In the North American session, EUR/USD is trading at 1.1291, down 0.43% on the day.

This week’s calendar in Europe is thin, which has the markets looking ahead to next week’s ECB policy meeting. There are no expectations for any changes in monetary policy at the meeting. The eurozone has not been immune to higher inflation. Although weaker than what the U.S. and U.K. have been experiencing, some ECB members have expressed unease about rising inflation.

Another key issue on the plate of bank policy-makers is QE. The ECB’s 1.85 trillion euro Pandemic Emergency Purchase Program (PEPP) has been in place since March 2020. Although the eurozone continues to struggle with COVID, the economy is showing improvement and the bank plans to wind up PEPP in March 2022.

The burning question is what to do with the bank’s Asset Purchase Program (APP), which has been utilized to keep inflation close to the 2% target and is running at 20 billion euros per month. There are fears that the termination of the PEPP will hurt eurozone members that are heavily indebted, and could cause a "cliff effect." The ECB is leaning to increase the APP after the PEPP winds up, but there is a disagreement within the ECB if increasing APP is the way to go. With the eurozone on the path to recovery and inflation on the rise, hawkish ECB members are pushing for the bank to tighten policy rather than increase QE.

Financial markets have shown plenty of volatility since Omicron appeared on the scene and caused a panic over fears of a new COVID wave. The World Health Organization is saying that it will need 2-3 weeks to have a more thorough understanding of Omicron. It is also unclear at this stage how effective the Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) vaccines are against Omicron, although preliminary reports have been positive, which has helped risk appetite rebound this week.

EUR/USD Technical

EUR/USD Daily Chart.

  • EUR/USD has support at 1.1236 and 1.1163
  • The next resistance lines are 1.1383 and 1.1457

Original Post

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.